Leaving MSDLink.ie
You are about to exit this MSD Ireland website. MSD Ireland makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information. Inclusion of any third party link does not imply an endorsement or recommendation by MSD Ireland.
This site is intended for health care professionals of Ireland.
Copyright © 2009-2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
tcm:4475-69879-4 Zoely /products/zoely/ sameWindow Primary tcm:4475-496620-64 010_About Zoely about.xhtml tcm:4475-496621-64 020_An Innovative COC innovative-coc.xhtml tcm:4475-535901-64 030_Patient Selection patient-selection.xhtml tcm:4475-496622-64 040_Progestin: NOMAC progestin-nomac.xhtml tcm:4475-496623-64 050_Estrogen: E2 estrogen-e2.xhtml tcm:4475-496624-64 060_Efficacy efficacy.xhtml tcm:4475-496625-64 070_Short, Light Bleeding short-light-bleeding.xhtml tcm:4475-496626-64 080_Optimised 24/4 Dosing optimised-dosing.xhtml tcm:4475-496628-64 110_Summary summary.xhtml tcm:4475-496629-64 120_Professional Resources professional-resources.xhtml tcm:4475-496630-64 122_-Support Materials support-materials.xhtml tcm:4475-496631-64 124_-Visuals and Videos visuals-videos.xhtml tcm:4475-496632-64 126_-Slide Sets slide-sets.xhtml tcm:4475-496634-64 130_Patient Resources patient-resources.xhtml tcm:4475-496635-64 132_-Patient Information patient-information.xhtml tcm:4475-496636-64 134_-Support Materials Resources support-materials-resources.xhtml tcm:4475-518758-64 140_Abbreviated Prescribing Information abbreviated-prescribing-information.xhtml tcm:4475-496639-64 LeftNav_Zoely leftnav.xml tcm:4475-497262-64 Study Design study-design.xhtml False
tcm:4475-496620-64
tcm:4475-496620-64 010_About Zoely about.xhtml
tcm:4475-496620-64 010_About Zoely about.xhtml
ZOELY (nomegestrolacetate, estradiol)
ZOELY is therapeutically indicated for oral contraception. The decision to prescribe Zoely should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Zoely compares with other CHCs.
Zoely is a combined oral hormonal contraceptive pill. Each white, active-film-coated tablet contains both an oestrogen and a progestogen, 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2, as hemihydrate). Zoely provides an oestrogen identical to that produced in a woman’s ovaries and a progesterone-derived progestogen with a 46-hour half-life. It is taken every day with no breaks and has a 24-hour missed-pill window.
Please consult medicines.ie for further information
SPC: Click here
PIL: Click here